San Francisco, CA4 Active Studies

Hidradenitis Suppurativa Clinical Trials in San Francisco, CA

Find 4 actively recruiting hidradenitis suppurativa clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
6,060
Enrolling

Recruiting Hidradenitis Suppurativa Studies in San Francisco

About Hidradenitis Suppurativa Clinical Trials in San Francisco

Hidradenitis suppurativa is a chronic skin condition causing painful lumps under the skin, typically in areas where skin rubs together. It can lead to tunnels under the skin and scarring. Treatment includes antibiotics, biologics, and surgical interventions.

There are currently 4 hidradenitis suppurativa clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 6,060 participants. Research is being sponsored by University of California, San Francisco, Children's Hospital Medical Center, Cincinnati, Amgen. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hidradenitis Suppurativa Clinical Trials in San Francisco — FAQ

Are there hidradenitis suppurativa clinical trials in San Francisco?

Yes, there are 4 hidradenitis suppurativa clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What hidradenitis suppurativa treatments are being tested?

The 4 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for hidradenitis suppurativa.

Data updated August 29, 2026 from ClinicalTrials.gov